Aptar Reports Second Quarter 2025 Results
AptarGroup, Inc. (
NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year.
Aptar Declares Quarterly Dividend
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is August 14, 2025 to stockholders of record as of July 24, 2025.
Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of the World’s Most Sustainable Companies 2025 by TIME. Aptar is ranked 244 out of 500 global companies evaluated by TIME and its partner Statista.
Aptar to Participate in Upcoming Investor Conferences
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it will present at two upcoming investor conferences:
Aptar Releases 2024 Corporate Sustainability Report
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2024 Corporate Sustainability Report entitled Progress Takes Shape. Aptar’s report highlights key milestones of its global sustainability strategy across the company’s global operations focused on three key pillars:
Aptar Reports First Quarter 2025 Results
AptarGroup, Inc. (
NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first quarter results for the period ended March 31, 2025, as compared to the corresponding period of the last fiscal year.
Aptar Declares Quarterly Dividend
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025.
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform. The platform was developed by Aptar’s drug services company, Nanopharm. If validated, SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals by proving it can accurately predict clinical outcomes – removing a major barrier for pharma companies and regulators and paving the way for wider patient access to medications. This validation would establish SmartTrack™ as a credible in-vitro-in-silico alternative to comparative clinical endpoint (CCEP) studies, and a reliable approach to derisking in vitro-pharmacokinetic (PK) only approaches, specifically for generic inhaled drug products.
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among the top 1% of the more than 150,000 companies rated by EcoVadis across all industries.
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the seventh consecutive year and is ranked number 26 out of the top 100 companies for 2025.
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the global environmental non-profit CDP, securing a place on its prestigious “A List.”
